Steven M Jones1, 2, 9, Heinz Feldmann1, 3, 9, Ute Ströher1, 3, Joan B Geisbert4, Lisa Fernando1, Allen Grolla1, Hans-Dieter Klenk5, Nancy J Sullivan6, Viktor E Volchkov7, Elizabeth A Fritz4, Kathleen M Daddario8, Lisa E Hensley4, Peter B Jahrling4
& Thomas W Geisbert41
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba
R3E 3R2, Canada.
2
Department of Immunology, University of Manitoba, Winnipeg, Manitoba
R3E 3R2, Canada.
3
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba
R3E 3R2, Canada.
4
United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Maryland
21702, USA.
5
Institute of Virology, Philipps-University, Robert Koch Str. 17, 35037, Marburg, Germany.
6
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 40 Covent Drive, Bethesda, Maryland, USA.
7
Filovirus Laboratory, University Claude Bernard Lyon-1, INSERM U412, 69007
Lyon, France.
8
Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, Maryland
20814, USA.
9
These authors contributed equally to this work.
Correspondence should be addressed to Heinz Feldmann Heinz_Feldmann@hc-sc.gc.ca
